To read the full story, subscribe or sign in.

Medical IP wins green light from FDA for its medical 3D printing software Medip

Dec. 27, 2019

HONG KONG – South Korea’s Medical IP Co. Ltd., an artificial intelligence (AI)-based medical 3D printing and software company, has won the FDA’s nod for its medical imaging analysis solution Medical Image Processing (Medip).

Medical technology Regulatory Software 3D printing Digital health Asia-Pacific FDA

Today's news in brief

BioWorld

BioWorld briefs for May 29, 2026.

TROP2 ADCs progress into first-line for lung, breast cancers

BioWorld

Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...

Illustration of antibodies and viral infection

New evidence links autoimmunity to long COVID symptoms

BioWorld

Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...

Will Ovid’s golden age of KCC2 metamorph CNS?

BioWorld

The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...

BMS-Hengrui deal strikes panic in Washington

BioWorld

On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...